Jane Warwick

Dr. Jane Warwick is a Professor of Clinical Trials Statistics and Principal Statistician at the Wolfson Institute of Population Health, Queen Mary University of London. With over 25 years of experience, she specializes in medical statistics, epidemiology, and clinical trials, particularly in cancer prevention and Bayesian methods. Her career includes leadership roles at the University of Birmingham, Imperial College London, and Warwick Clinical Trials Unit, where she advanced adaptive trial designs in mental health and orthopaedic surgery.

Education: PhD in Medical Statistics (2001) at the Cancer Research UK Centre for Cancer Prevention, followed by postdoctoral work at Queen Mary University of London under Professors Stephen Duffy and Jack Cuzick. She later led statistics teams at Imperial and Warwick Clinical Trials Units before returning to Queen Mary in 2021 as a statistical consultant for cancer screening and prevention trials.

Research Interests: Focus on optimizing clinical trial methodologies (Bayesian adaptive designs), cancer aetiology, and prevention strategies. Key areas include breast and ovarian cancer risk prediction, screening program evaluation, and translational research in mental health and orthopaedics.

Professional Contributions: No awards explicitly listed, but her extensive leadership in clinical trials across multiple institutions underscores her expertise. Currently advises the Cancer Prevention Trials Unit and collaborates with global teams on population health initiatives.

Labs/Teams: Active member of the Cancer Prevention Trials Unit and former leadership roles in clinical trial units at Imperial and Warwick Universities.